BDKRB2 and congenital rubella syndrome: Since none of the patients we recruited in this study had a history of allergy or asthma sensitivity, our findings suggest that BK can serve as an important player in CRS and BK and B2R may be taken as a therapeutic target for treating/preventing CRS.